Especially for high-risk and cis tumors.
Profitable
Measure yourself and bill yourself
Product description
Quantitative rapid test for bladder cancer diagnosis
For patients at high risk of bladder cancer, a regular rapid test can contribute to early detection. CancerCheck® UBC Rapid® can be measured quantitatively. This offers advantages over simple yes/no tests, because the quantitative result enables better risk assessment and complements the monitoring of bladder cancer patients. The higher the measured value, the higher the risk. CancerCheck® UBC Rapid detects soluble fragments of cytokeratin 8 and 18 in urine samples.
Technical details
Format quantitative immunochromatographic in vitro test
Measuring range 5-300 μg/l
Number of pieces 20
Storage temperature 2-25 °C